Can-Fite BioPharma Ltd. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Can-Fite BioPharma Ltd. (CANF) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $10.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-26
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|
| 2025-12-31 | $10.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $9.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | -$22.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | -$19.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | $98.00K 20-F · filed 2026-03-26 | |
| 2022-12-31 | -$113.00K 20-F · filed 2025-04-14 | |
| 2022-06-30 | -$92.00K 6-K · filed 2023-08-31 | |
| 2021-12-31 | $34.00K 20-F · filed 2024-03-28 | |
| 2020-12-31 | -$23.00K 20-F · filed 2023-03-30 |